2021 CMSC Annual Meeting


Poster-Symptom Management

Implementation of a Depression Screening Tool (PHQ-9) for Adult Multiple Sclerosis Patients at an Outpatient Neurology Clinic.

Background: Depression is the most common symptom in Multiple Sclerosis (MS) patients with reported lifetime prevalence of 25-50%....

Read More

Poster-Quality of Life and Outcomes

The Can Do Multiple Sclerosis Outcomes Study: Study Design to Evaluate Program Outcomes

Background: Assessment of self-efficacy has been a focus of Can Do MS programs given prior research showing associations between higher...

Read More

Poster-Methods of Care

Development and Implementation of a Psychoeducational Model for a Pediatric MS Clinic Transition Program

Background: Multiple Sclerosis (MS) is less commonly diagnosed in children than in adults with an estimated prevalence of 5,000 in the US...

Read More

Poster-Disease-modifying Therapy

Analysis of Health Care Provider Reasons for Switching to Diroximel Fumarate from Other Disease-Modifying Therapies

Background: Switching of disease-modifying therapies (DMTs) for treatment of multiple sclerosis (MS) is driven by many factors that are not...

Read More